Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation

Journal of Hepatology

Volumn 28, Issue 3, 1998, Pages 410-416

  Leclercq, Isabelle ^a   Horsmans, Yves ^a   Desager, Jean Pierre ^a   Delzenne, Nathalie ^a   Geubel, André Pierre ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Duck; Fatty liver; High glucidic diet; Nutrition; Rat

Indexed keywords

AMINOPYRINE N DEMETHYLASE; CHLORZOXAZONE; CYTOCHROME P450; ERYTHROMYCIN; N DEMETHYLASE; OXYGENASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCK; ENZYME ACTIVITY; ENZYME INDUCTION; FATTY LIVER; INFLAMMATION; LIPID COMPOSITION; LIVER MICROSOME; LIVER TOXICITY; MALE; NONHUMAN; NUTRITION; PRIORITY JOURNAL; RAT; STEATOSIS;

EID: 0032030819     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80314-0     Document Type: Article

References (27)

1. Alpers DH, Sabesin SM, White HM. Fatty liver: biochemical and clinical aspects. Schiff L, Schiff ER. 7th ed. Diseases of the Liver. 1993;825-871 JB Lippincott Company, Philadelphia.
2. Burt AD, MacSween RNM, Peters TJ, Simpson KJ. Non-alcoholic fatty liver: causes and complications. McIntyre N, Benhamou JP, Bircher J, Rizetto M, Rodes J. Oxford Textbook of Clinical Hepatology. 2:1991;865-871 Oxford University Press, Oxford.
3. Acheson KJ, Schutz Y, Bessard T, Ravussin E, Jequier E, Flatt JP. Nutritional influences on lipogenesis and thermogenesis after a carbohydrate meal [editorial]. Am J Physiol. 246:1984;62-70.
4. Bentley JB, Vaughan RW, Gandolfi AJ, Cork RC. Halothane biotransformation in obese and non-obese patients. Anesthesiology. 57:1982;94-97.
5. Corcoran GB, Wrong BK. Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat. J Pharmacol Exp Ther. 241:1987;921-927.
6. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology. 111:1996;1645-1653.
7. Delzenne ND, Hernaux NA, Taper HS. A new model of acute liver steatosis induced in rats by fasting followed by refeeding a high carbohydrate-fat free diet: biochemical and morphological analysis. J Hepatol. 26:1997;880-885.
8. Matsubara T, Touchi A, Ogawa A. Heterogeneous distribution of the cytochrome P-450 monooxygenase system in rat liver lobes. Jpn J Pharmacol. 32:1982;999-1011.
9. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 37:1959;911-917.
10. Tietz N. Fundamentals of Clinical Chemistry. 1976;492-494 WB Saunders Company, Philadelphia.
11. Guengerich FP. Preparation and properties of highly purified cytochrome P-450 and NADPH-cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits. Mol Pharmacol. 13:1977;911-923.
12. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
13. Omura T, Sato R. The carbon monoxide binding pigment of liver microsomes. II. Solubilization, purification and properties. J Biol Chem. 239:1964;2370-2385.
14. Nash T. The colorimetric estimation of formaldehyde by means of the Hantsch reaction. J Biochem. 239:1953;416-421.
15. Horsmans Y, Stevens M, Geubel A, Harvengt C, Rahier J. Immunoquantification of cytochrome P-450 3A on rat paraffin embedded liver tissue. Liver. 12:1992;344-350.
16. Peter R, Böcker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem Res Toxicol. 3:1990;566-573.
17. Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, et al. Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci USA. 82:1985;6310-6314.
18. Johansson I, Kstrom G, Scholte B, Puzychi D, Jornvall H, Ingelman-Sundberg M. Ethanol-fasting- and acetone-inducible P450 in rat liver. Regulation and characteristics of enzymes belonging to the IIB and IIE gene subfamilies. Biochemistry. 27:1988;1925-1934.
19. Beaune P, Kremers P, Letawe-Goujon F, Gielen JE. Monoclonal antibodies against human liver cytochrome P-450. Biochem Pharmacol. 34:1985;3547-3552.
20. Friedman LS, Martin P, Munoz SJ. Liver function tests and the objective evaluation of the patient with liver disease. Zakim D, Boyer TD. 3rd ed. Hepatology: a Textbook of Liver Disease. 1996;791-832 W.B. Saunders Company, Philadelphia.
21. Hermier D, Rousselot-Pailley D, Peresson R, Sellier N. Influence of orotic acid estrogen on hepatic lipid storage and secretion in the goose susceptible to liver steatosis. Biochim Biophys Acta. 1211:1994;97-106.
22. Iritani N, Nishimoto N, Katsurada A, Fukuda H. Regulation of hepatic lipogenic enzyme gene expression by diet quantity in rats fed a fat-free, high-carbohydrate diet. J Nutr. 122:1992;28-36.
23. Knodell RG, Whitmer DI, Holman RT. Influence of hyperalimentation on rat hepatic microsomal fluidity and function. Gastroenterology. 98:1990;1320-1325.
24. Imaoka S, Imai Y, Shimada T, Funae Y. Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity. Biochemistry. 31:1992;6063-6069.
25. Leclercq I, Horsmans Y, Desager JP, Pauwels S, Geubel AP. Influence of diet on liver volume and cytochrome P-450 (CYP) activities in human non-alcoholic fatty liver [abstract]. Hepatology. 24:1996;311.
26. Tapner M, Liddle C, Goodwin B, George J, Farrell GC. Interferon gamma down regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology. 24:1996;367-373.
27. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary cultures. Mol Pharmacol. 44:1993;707-715.